Evaluation of nonneoplastic findings on vaginal smears with comparison of intrauterine devices and oral contraceptive pill effects
Although the Pap smear is a common screening test for cervical cancer and its precursors, it can detect some benign conditions as well. In this study, the aim was to evaluate smear results with regard to nonneoplastic findings and to compare them to the detectable effects of intrauterine devices (IUDs) and oral contraceptive pills (OPs). Materials and methods: In this retrospective study, the hospital records and cytopathology reports of 4248 patients were recorded. Smear results were evaluated according to the 2001 Bethesda System and were evaluated according to age groups, menopausal/menstrual status, physical examination findings, and contraceptive method usage. Results: Of the 4248 patients, 75% were menstruating and 25% were menopausal. The most common smear result was nonspecific inflammation (NSI). In comparing the IUD (n = 730) and OP (n = 322) groups, we found Candida species, Actinomyces, and bacterial vaginosis to be significantly higher in the IUD-using group, while NSI, discharge, and erosion were found to be significantly higher in the OP group. Conclusion: Pap smears can provide information about infectious diseases that can occur in the cervicovaginal region. These results reflect the fact that the IUDs disrupt vaginal flora more than OPs do.
Evaluation of nonneoplastic findings on vaginal smears with comparison of intrauterine devices and oral contraceptive pill effects
Although the Pap smear is a common screening test for cervical cancer and its precursors, it can detect some benign conditions as well. In this study, the aim was to evaluate smear results with regard to nonneoplastic findings and to compare them to the detectable effects of intrauterine devices (IUDs) and oral contraceptive pills (OPs). Materials and methods: In this retrospective study, the hospital records and cytopathology reports of 4248 patients were recorded. Smear results were evaluated according to the 2001 Bethesda System and were evaluated according to age groups, menopausal/menstrual status, physical examination findings, and contraceptive method usage. Results: Of the 4248 patients, 75% were menstruating and 25% were menopausal. The most common smear result was nonspecific inflammation (NSI). In comparing the IUD (n = 730) and OP (n = 322) groups, we found Candida species, Actinomyces, and bacterial vaginosis to be significantly higher in the IUD-using group, while NSI, discharge, and erosion were found to be significantly higher in the OP group. Conclusion: Pap smears can provide information about infectious diseases that can occur in the cervicovaginal region. These results reflect the fact that the IUDs disrupt vaginal flora more than OPs do.
___
- Bukhari MH, Majeed M, Qamar S, Niazi S, Syed SZ, Yusuf AW et al. Clinicopathological study of Papanicolaou (Pap) smears for diagnosing of cervical infections. Diagn Cytopathol 2012: 40: 35–41.
- Powers CN. Diagnosis of infectious diseases: a cytopathologist’s perspective. Clin Microbiol Rev 1998; 11: 341–65.
- Michalas SP. The Pap test: George N. Papanicolaou (18831962). A screening test for the prevention of cancer of uterine cervix. Eur J Obstet Gynecol Reprod Biol 2000; 90: 135–8.
- Papanicolaou GN. A new procedure for staining vaginal smears. Science 1942; 95: 438–9.
- Vuopala S, Klemi PJ, Mäenpää J, Salmi T, Mäkäräinen L. Endobrush sampling for endometrial cancer. Acta Obstet Gynecol Scand 1989; 68: 345–50.
- Eriksson K, Forsum U, Bjornerem A, Platz-Christensen JJ, Larsson PG. Validation of the use of Pap-stained vaginal smears for diagnosis of bacterial vaginosis. APMIS 2007; 115: 809–13.
- Nayar R, Solomon D. Support from authors of the Bethesda system. Cytopathology 2008; 19: 399–400.
- Turkish Cervical Cancer and Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009; 106: 206–9.
- Gupta S, Kumar N, Singhal N, Manektala U, Jain S, Sodhani P. Cytohormonal and morphological alterations in cervicovaginal smears of postmenopausal women on hormone replacement therapy. Diagn Cytopathol 2006; 34: 676–81.
- Chalechale A, Karimi I. The prevalence of Trichomonas vaginalis among patients that presented to hospitals in the Kermanshah district of Iran in 2006-2007. Turk J Med Sci 2010; 40: 971–5.
- Al-Hindi AI, Lubbad AMH. Trichomonas vaginalis infection among Palestinian women: prevalence and trends during 2000-2006. Turk J Med Sci 2006; 36: 371–5.
- Cherpes TL, Marrazzo JM, Cosentino LA, Meyn LA, Murray PJ, Hillier SL. Hormonal contraceptive use modulates the local inflammatory response to bacterial vaginosis. Sex Transm Infect 2008; 84: 57–61.
- Demirezen S, Küçük A, Beksaç MS. The association between copper containing IUCD and bacterial vaginosis. Cent Eur J Public Health 2006; 14: 138–40.
- Zipper JA, Tatum HJ, Pastene L, Medel M, Rivera M. Metallic copper as an intrauterine contraceptive adjunct to the “T” device. Am J Obstet Gynecol 1969; 105: 1274–8.
- Smayevsky J, Canigia LF, Lanza A, Bianchini H. Vaginal microflora associated with bacterial vaginosis in nonpregnant women: reliability of sialidase detection. Infect Dis Obstet Gynecol 2001; 9: 17–22.
- Demirezen S. Review of cytologic criteria of bacterial vaginosis: examination of 2,841 Papanicolaou-stained vaginal smears. Diagn Cytopathol 2003; 29: 156–9.
- Ocak S, Cetin M, Hakverdi S, Dolapcioglu K, Gungoren A, Hakverdi AU. Effects of intrauterine device and oral contraceptive on vaginal flora and epithelium. Saudi Med J 2007; 28: 727–31.
- Tendolkar U, Pandit D, Khatri M, Deodhar L. Actinomyces species associated with intrauterine contraceptive devices and pelvic inflammatory disease. Indian J Pathol Microbiol 1993; 36: 238–44.
- Mao K, Guillebaud J. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms. Contraception 1984; 30: 535–44.
- Westhoff C. IUDs and colonisation or infection with Actinomyces. Contraception 2007; 75: 48–5.
- Batashki I, Markova D, Milchev N, Uchikova E, Gŭrova A. Effect of oral contraceptives on vaginal flora. Akush Ginekol 2006; 45: 49–51.